PRU vs RARE · rev $31.19B vs rev $350.0M
PRU (PRU) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
PRU (PRU) common stock.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported PRU revenue for 2026-06-30 was $31.19B. Net income was $1.58B. PRU currently screens at market cap $0.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
PRU currently screens at market cap $0. RARE currently screens at market cap $2.79B.
Not investment advice. Open the PRU and RARE stock pages for the full models.
Not investment advice.